Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
National Journal of Andrology
>
2013
>
19
>
6
Volume:
19
Issue:
6
1. Benign prostatic hyperplasia and erectile dysfunction: an update.
Page:572—575
2. PSA-based screening for prostate cancer: a comparative analysis.
Page:559—562
3. Molecular mechanisms of leupaxin involved in prostate carcinoma metastasis.
Page:555—558
4. Therapeutic efficacy of compound Xuanju capsule on type III prostatitis.
Page:551—554
5. Clinical efficacy and relative factors of dendritic cell-based tumor vaccination for prostate cancer: a systematic review and meta-analysis.
Page:545—550
6. Clinical efficacy of daily low-dose tadalafil on erectile dysfunction-no sexual life.
Page:542—544
7. Low-dose tadalafil for erectile dysfunction following pelvic fracture-induced urethral injury: clinical observation of 42 cases.
Page:539—541
8. Testicular cellular fibroma: a clinicopathological observation.
Page:535—538
9. Transurethral seminal vesiculoscopy for refractory or recurrent hemospermia: clinical analysis of 162 cases.
Page:531—534
10. Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis.
Page:527—530
11. Late-onset hypogonadism among old and middle-aged males in a rural community of Zhejiang Province.
Page:522—526
12. Male sexual dysfunction and Parkinson's disease: a preliminary investigation.
Page:518—521
13. Correlation of DNA methylation status of imprinted gene H19 ICR with oligozoospermia and asthenozoospermia.
Page:511—517
14. Inhibitory effect of cocoomyxa gloeobotrydifomis on benign prostate hyperplasia in aged rats and its action mechanism.
Page:506—510
15. Inhibitory effect of Akt inhibitor deguelin on the growth of PC-3 prostate cancer cells.
Page:501—505
16. Tea polyphenols inhibits the proliferation of prostate cancer DU145 cells.
Page:495—500
17. Impact of NF-kappaB inhibitor on STAT3 translocation in PC-3 prostate cancer cell line.
Page:487—494
18. Establishment of an in vitro screening model for steroid 5 alpha-reductase inhibitors with the microplate reader.
Page:483—486